GGrantIndex
Sort

48,018 grants matching immunotherapy

Molecular mechanisms of CD8 T cell fate decision instructed by cytokine signaling

$566,110
Takeshi Egawa · Washington University · R01 · FY2025 · AI

SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT

$566,053
Pal Ranajit · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI

Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis

$566,035
Christine A Petersen · Ohio State University · R01 · FY2024 · AI

Clinical Trials Exploiting NK Cell Activity

$566,011
Daniel J Weisdorf · University Of Minnesota · P01 · FY2020 · CA

Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity.

$565,997
James J Pestka · Michigan State University · R01 · FY2024 · ES

Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity.

$565,997
James J Pestka · Michigan State University · R01 · FY2025 · ES

In Vitro Approach To Problems of Clinical Allergy

$565,981
Johns Hopkins University · R01 · FY2004 · AI

Monoclonal antibody isolation and characterization

$565,970
Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Combinatorial Immunotherapy using a Multivalent Drug Conjugate for GBM Treatment

$565,969
Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2024 · CA

Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors

$565,936
Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2023 · CA

Project 2: A Novel Cellular Tumor Vaccine Strategy for Glioblastoma

$565,823
Michael D Gunn · Duke University · P01 · FY2021 · CA

The transcription factor c-MYC in lymphocyte expansion and restriction of stemness

$565,821
Takeshi Egawa · Washington University · R01 · FY2023 · AI

The transcription factor c-MYC in lymphocyte expansion and restriction of stemness

$565,821
Takeshi Egawa · Washington University · R01 · FY2024 · AI

The transcription factor c-MYC in lymphocyte expansion and restriction of stemness

$565,821
Takeshi Egawa · Washington University · R01 · FY2025 · AI

Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer

$565,815
Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2024 · CA

Developmental Funds

$565,768
Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2017 · CA

Targeting Amino Acid Metabolism in Glioblastoma

$565,760
Jeremy N Rich · Univ Of North Carolina Chapel Hill · R01 · FY2025 · NS

"Off-the-Shelf" iPSC-Derived Regulatory T Cell Immunotherapeutics

$565,672
Bruce R. Blazar · University Of Minnesota · P01 · FY2024 · CA

CD4 T cell control of cytomegalovirus

$565,653
Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2023 · AI

ITIM-receptors for cancer treatment

$565,597
Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA

Improving response durability after CAR T cell therapy for multiple myeloma

$565,591
Michael C. Milone · University Of Pennsylvania · P01 · FY2024 · CA

Image-guided TRAIL-enhanced CAR T-cell immunotherapy

$565,587
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Developmental Funds

$565,470
Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2019 · CA

Developmental Funds

$565,470
Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA

Treating colon cancer by regulating intestinal immunity through microbial metabolism

$565,434
Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2025 · CA